Skip to main content
Erschienen in: Italian Journal of Pediatrics 1/2018

Open Access 01.12.2018 | Case report

A child with intellectual disability and dysmorphism due to complex ring chromosome 6: identification of molecular mechanism with review of literature

verfasst von: Frenny Sheth, Thomas Liehr, Viraj Shah, Hillary Shah, Stuti Tewari, Dhaval Solanki, Sunil Trivedi, Jayesh Sheth

Erschienen in: Italian Journal of Pediatrics | Ausgabe 1/2018

Abstract

Background

Ring chromosome 6 (r(6)) is a rare disorder that mainly occurs as a ‘de novo’ event. Nonetheless, a wide phenotypic spectrum has been reported in r(6) cases, depending on breakpoints, size of involved region, copy number alterations and mosaicism of cells with r(6) and/or monosomy 6 due to loss of r(6).

Case presentation

An 11-year-old male was referred with developmental delay, intellectual disability and microcephaly. Physical examination revealed additionally short stature and multiple facial dysmorphisms. Banding cytogenetic studies revealed a karyotype of mos 46,XY,r(6)(p25.3q27)[54]/45,XY,-6[13]/46,XY,r(6)(::p25.3→q27::p25.3→q27::)[13]/46,XY[6]/47,XY,r(6)(p25.3q27)×2[2]dn. Additionally, molecular karyotyping and molecular cytogenetics confirmed the breakpoints and characterized a 1.3 Mb contiguous duplication at 6p25.3.

Conclusion

The present study has accurately identified copy number alterations caused by ring chromosome formation. A review of the literature suggests that hemizygous expression of TBP gene in 6q27~qter, is likely to be the underlying cause of the phenotype. The phenotypic correlation and clinical severity in r(6) cases continue to remain widely diverse in spite of numerous reports of genomic variations.
Abkürzungen
DLL1
Delta like canonical notch ligand 1
DUSP22
Dual specificity phosphatase 22
EXOC2
Exocyst complex component 2
FAM120B
Family with sequence similarity 120B
FISH
Fluorescence in situ hybridization
FOXC1
Forkheadbox C1
FOXCUT
FOXC1 upstream transcript
FOXF2
Forkheadbox F2
FOXQ1
Forkhead box protein Q1
GMDS
GDP-mannose 4,6-dehydratase
HUS1B
HUS1 checkpoint clamp component B
IRF4
Interferon regulatory factor 4
ISCN
International System for Human Cytogenetic Nomenclature
MIR4644
MicroRNA 4644
PDCD2
Programmed cell death 2
PSMB1
Proteasome subunit beta type-1
r(6)
Ring chromosome 6
SNP
Single nucleotide polymorphism
TBP
TATA-binding protein

Background

Ring chromosome 6 (r(6)) is an exceedingly rare disorder, first described in 1973 by Moore et al. [1]. Since then, >30 patients with this condition have been reported [2]. Formation of ring chromosomes usually occurs due to breaks in the terminal portions of both the chromosome arms, followed by the fusion of broken ends. Alternatively, they can be formed by the union of subtelomeric sequences or telomere-telomere fusion with no deletion, resulting in a complete ring chromosome. Such complete rings without apparent significant loss of genetic material have been described in individuals with normal phenotypes [3]. Other mechanisms for ring chromosome formation, like terminal deletions, and/ or contiguous inverted duplication due to an inv-dup-del rearrangement/s have also been proposed in the literature [46], also recently chromothripsis has been attributed as a possible reason for such cases [7].
Even though being rare, a wide spectrum of phenotypic variability is observed in all cases of autosomal ring chromosomes. Congenital heart defects, intellectual disability, microcephaly, facial dysmorphism, failure to thrive and various abnormalities in the ocular, auditory and central nervous systems are frequently detected [8].
In this study, a mosaic r(6) in a clinically abnormal, 11-year-old male was characterized in detail and compared with cases from the literature to share some new insights into the genotype-phenotype correlations.

Case presentation

An 11-year-old male was referred for further diagnostics due to developmental delay, intellectual disability and microcephaly. He was the first child born to apparently healthy non-consanguineous parents. The mother had an uneventful pregnancy with no history of prenatal exposure to alcohol, drug or tobacco. Though his siblings (7-year brother and 3 years old sister) were phenotypically normal, his paternal cousin-sister was microcephalic and mentally challenged. No investigations were carried out in the affected cousin-sister.
The proband was born by normal vaginal delivery. The birth weight was 1.5 kg and head circumference was 33 cm. Apgar score at birth was within the normal range. The patient was sitting without support at around 1.5 years. He could stand with support by 2 years and independent walking at 2.5 years. His speech development was delayed. He was not able to speak sentences and could not achieve proper bowel and bladder control even at the time of presentation (11 years). His height and weight were 108 cm and 14.5 kg respectively (below 10th centile); head circumference (OFC; Occipital Frontal Circumference) was 42 cm (below 3rd centile). The proband portrayed short stature and microcephaly with developmental delay. The facial dysmorphism showed long face, small chin, large protruding ears, slightly upturned eyes, sparse eyebrows, large bulbous nose and thin upper lip (Fig. 1a and b). Speech delay, penile chordee and sacral dimple were also noted during physical examination. His respiratory, cardiovascular and abdominal examinations were unremarkable. CNS examination showed intellectual disability, delayed language development and hyperactivity. His speech and cognitive development was more delayed than his motor milestones, and academic performance was very poor. His serum TSH (thyroid stimulating hormone) and GH (growth hormone) levels were normal. Magnetic resonance imaging (MRI; performed at an age of 10 years) showed demyelination in both frontal and parietal lobes (Fig. 2). Ultrasonography of abdomen and pelvis were normal, as were echocardiogram and ophthalmologic examinations.
Sample collection and written informed consent was obtained according to the need of the institutional ethics committee in accordance with Helsinki declaration. Chromosome analysis of the patient was performed with 72 h lymphocyte culture and standard GTG-banding. The karyotype was interpreted according to the International System for Human Cytogenetic Nomenclature (ISCN 2016) [9] as mos 46,XY,r(6)(p25.3q27)[54]/45,XY,-6[13]/46,XY,r(6)(::p25.3→q27::p25.3→q27::)[13]/46,XY[6]/47,XY,r(6)(p25.3q27)×2[2]dn (Fig. 3).
Karyotype of the parents was normal, confirming a ‘de novo’ origin of the r(6). Further analysis was carried out by molecular karyotyping using Affymetrix CytoScan™ 750 K array. Data was analyzed using Chromosome Analysis Suite (ChAS) and revealed: arr [GRCh37] 6pterp25.3(156,974_665,234)x1,6p25.3(668,700_1,929,528)x3,6q27qter(170,466,513_170,914,297)×1. In other words, there was a partial terminal monosomy of overall 508 kb in 6p25.3 followed by a 1.3 Mb contiguous duplication in 6p25.3 and 448 kb terminal deletion in 6q27 (Fig. 4). These results were confirmed by fluorescence in situ hybridization (FISH) using commercially available subtelomeric probes for 6pter and 6qter. The duplicated region in 6p25.3 could not be confirmed by another method due to lack of corresponding locus-specific probes. The dicentric nature of double ring was thus established by a centromeric probe (Fig. 5).

Discussion and conclusions

Ring chromosome 6 is a rare event, that generally occurs as a ‘de novo’ event. Inheritance of ring chromosomes is quite infrequent since it is unstable during cell division with a possible loss of the ring during meiosis. Moreover, ring chromosome carriers may be infertile due to the chromosomal alteration.
Postnatal growth failure and microcephaly are the leading features of any autosomal ring chromosome; also they tend to show dynamic mosaicism, as observed in the present case. Patients with r(6) syndrome frequently present with growth retardation, facial dysmorphism and microcephaly. The additional clinical features of the present case can most likely be attributed to the cryptic duplication event in the r(6).
Major features associated either with 6p or 6q terminal deletions include defects of the anterior eye-chamber development, hearing loss, heart malformations, hypertelorism, mid-face hypoplasia, low set ears, developmental delay, intellectual disability, hypotonia, seizures, facial dysmorphism, and short neck [10, 11]. Most of these findings are analogous to that noted in the proband under report which suggests that the phenotypic variability and severity may partially be attributed to existence and instability of the ring. Several mechanisms for such instability are proposed in the literature, without plausible explanation [3, 12]. Further, the severity of the phenotype is hypothesized to be related to the size of the deletion. Microcephaly, facial dysmorphism and cardiac abnormalities seem to be more prevalent in the patients with single cell line anomaly; conversely, growth retardation, intellectual disability and demyelination of frontal and parietal lobes were additional anomalies that were more frequent with multiple cell lines.
To establish genotype/phenotype correlations for r(6), we compared the clinical features of the case under report to previously reported cases of r(6) (Table 1; Fig. 6) and explored the deleted and duplicated regions for morbid genes, using OMIM database and DECIPHER (https://​decipher.​sanger.​ac.​uk/​).
Table 1
Comparative clinical features and cytogenetic results in various cases of ring chromosome 6
 
Single cell line (one of the chromosome #6 has been replaced by a ring chromosome 6)
Mosaicism (structural and numerical variants of ring chromosome #6 are present in various cell lines in different proportions)
2 cell lines
3 cell lines
4 cell lines
5 cell lines
 
Publications
Pace et al. [13]
Ciocca et al. [14]
Ahzad et al. [15]
Walker et al. [16]
Kini et al. [17]
Fried et al. [18]
Zhang et al. [19]
Fraction
Hurd et al. [20]
Lee et al. [8]
Andrieux et al. [21]
Kara et al. [22]
Nishigaki et al. [23]
Hockner et al. [24]
Nishi et al. [25]
Present case
Fraction
Karyotype
Not available
46,XX,r(6)(p25q27)
46,XY,r(6)(p25q27)
46,XY,r(6)(p25q27)
Not available
Not available
46,XY,r(6)(p25q27).ish r(6)(p25.1q27)
 
47, XY, +r [17]/48,XY, +rx2 [3] and second case
47, XY, +mar[12]/46,XY[3]
46, XY, r(6)(p25q27)/46, XY, dic r(6;6)(p25q27;p25q27)
46,XY,r(6)(p25q27)/45,XY-6
mos46,XY,r(6)(p24;q26),del(6)(q27) [30]/46,XY,del(6)(q27) [20]
mos 46,XX,r(6)(p25q27)[67]/45,XX,-6[25]/46,XX,dic r(6:6)(p25q27:p25q27)[6]/47,XX,r(6)(p25q27)× 2[2]
mos 46,XX,r(6)(p25.3q27)[16]/45,XX,-6[2]/46,XX,dic r(6:6)(p25.3q27:p25.3q27)[2]/47,XX,r(6)(p25.3q27) × 2[1]
Not available
mos 46,XY,r(6)(p25.3q27)[54]/45,XY,-6[13]/46,XY,r(6)(::p25.3→q27::p25.3→q27::)[13]/46,XY[6]/47,XY,r(6)(p25.3q27)×2[2]dn
 
Clinical features
 Microcephaly
 
6/7
 
7/8
 Facial dysmorphism
 
 
5/7
 
7/8
 Glaucoma
      
1/7
         
 Hearing loss
  
  
3/7
       
1/8
 Tachypnea
       
 
      
1/8
 Speech delay
       
   
  
3/8
 White matter abnormalities in brain
       
  
 
  
3/8
 Developmental delay
 
   
3/7
   
 
4/8
 Growth retardation
   
 
3/7
    
4/8
 Intellectual disability
  
  
 
2/7
   
 
4/8
 Scoliosis
      
1/7
     
  
1/8
 Cardiac anomalies (ASD,CHD,PDA)
    
3/7
 
      
1/8
 Abnormalities in the digits (brachydactyly/clinodactyly/bilateral syndactyly)
 
   
3/7
 
   
4/8
 Single palmar crease
  
    
1/7
        
 Penile chordee
       
       
1/8
 Sacral dimple
       
       
1/8
 Abnormalities in the foot
      
1/7
 
      
1/8
 Complex bone disorders
       
√ (2)
       
2/8
 Dry skin
      
1/7
        
 seizures
   
 
3/7
√ (2)
   
   
3/8
 Umbilical hernia
  
    
1/7
        
ASD atrial septal defect, CHD congenital heart defect, PDA patent ductus arteriosus
The deleted 508 kb subtelomeric region from 6pter to 6p25.3 contains 4 annotated genes: DUSP22, IRF4, EXOC2, HUS1B; IRF4 (*601900) being the only OMIM morbid gene. Interferon regulatory factor 4 (IRF4) is a transcription factor essential for the development of T helper 2 (Th2), Th17 and Th9 cells, whose allelic variant influences variation in skin/hair/eye pigmentation 8. Dysregulation of IRF4 is associated with lymphoid malignancies [29].
The duplicated segment of 1.3 Mb at 6p25.3 was larger in size and contained more relevant OMIM genes-three copies each of EXOC2, LOC285768, FOXQ1, FOXF2, FOXC1, GMDS, FOXCUT; FOXC1 being the only morbid gene amongst them. Mutations in Forkhead box C1; (FOXC1; *601090) has been associated with phenotypes like Anterior segment dysgenesis 3 and Axenfeld Reigen syndrome type 3. Nishimura et al. [30] in their study demonstrated that haploinsufficiency in addition to the mutations as well as increased gene dosage may cause anterior chamber defects of the eye. Later, Lehman et al. [31] reported an association between interstitial 6p25 duplications involving FOXC1 gene and ocular developmental abnormalities and glaucoma. Ophthalmologic examination in the patient under report did not reveal any abnormality and possibly point towards a less likely role of an extra copy of FOXC1 alone in the ophthalmological manifestations in such patients.
Apart from ocular manifestations, mutations and haploinsufficiency of FOXC1 gene have also been speculated to be implicated in cardiac abnormalities [2, 32]. However, there seem to be no reports to suggest for duplication. The patient under report had normal echocardiography findings. There is a paucity of data on the pathological manifestations of distal 6p duplication. Qi et al. elaborated on the same in 2015 study and concluded that copy number gain of this particular region is likely benign or triploinsensitive [33].
A terminal deletion (448 kb) was detected (from 6q27 to 6qter) that encompass LOC154449, DLL1, FAM120B, MIR4644, PSMB1, TBP, PDCD2 OMIM annotated genes. Amongst them, TATA-binding protein (TBP), a general transcription factor associates with aggregates in several polyglutamine disorders; is the only gene with a pathogenic potential [34]. A reasonable number of studies have postulated TBP as a potential candidate gene responsible for the phenotype of patients with subtelomeric 6q deletions, irrespective of the size of terminal deletion [35, 36]. Moreover, a study [37] has reported a ‘de novo’ missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene in 1/14 (7.1%) patient with periventricular nodular heterotopia, developmental delay and epilepsy through whole exome sequencing. In addition, the authors silenced C6orf70 and two additional genes (phf10 and Dll1) in the developing rat neocortex and suggested that C6orf70 plays a major role in the control of neuronal migration and its haploinsufficiency or mutation causes periventricular heterotropia.
Developmental delay, intellectual disability, dysmorphism, seizures, dimpling of elbows and knees are some of the main features noted in such patients. Most of the above mentioned clinical features were also seen in our patient, raising a strong possibility pointing towards the hemizygous expression of TBP might be implicated in the causation of the phenotype. Apart from these, the developmental delay, growth stunting and mild facial dysmorphism observed in the proband can also be attributed partially to the mitotic instability of the ring chromosome as the source of continuous production of secondary aneuploid cells [3, 25]. There is still a dearth of literature on ring chromosome 6 and therefore, further studies are advocated to understand the role of genes influencing such genotype-phenotypic presentations.

Acknowledgements

We would like to express our sincere thanks to Dr. Krati Shah for critical reading. We are grateful to the family of the patient for their kind co-operation and permission. We acknowledge the Gujarat State Biotechnology Mission (GSBTM) [Grant no.: GSBTM/MD/PROJECTS/SSA/505/4865/2016–17] for partly supporting the work.

Funding

This work is partly supported by Gujarat State Biotechnology Mission (GSBTM) [Grant no.: GSBTM/MD/PROJECTS/SSA/505/4865/2016–17]. The funding agency was not directly or indirectly involved in the study design, specimen collection, analysis, interpretation and preparation of the manuscript.

Availability of data and materials

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
• Present case under submission has been approved by the institutional ethics committee [FRIGE’s Institute of Human Genetics] wide approval number FRIGE/IEC/15/2016 dated 16th March, 2016. This process is in accordance with the Helsinki declaration.
• An informed consent was obtained from the parents before enrolling for the investigations [This was in accordance with the requirement of the institutional ethics committee].
• An informed consent for publication was also obtained from the parents [This was in accordance with the need of the institutional ethics committee].
Written informed consent was obtained from patient’s parents for publication of their clinical details. A copy of the written consent is available for review.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Moore CM, Heller RH, Thomas GH. Developmental abnormalities associated with a ring chromosome 6. J Med Genet. 1973;10:299–303.CrossRef Moore CM, Heller RH, Thomas GH. Developmental abnormalities associated with a ring chromosome 6. J Med Genet. 1973;10:299–303.CrossRef
4.
Zurück zum Zitat Seghezzi L, Maraschio P, Bozzola M, Maserati E, Tupler R, Marchi A, et al. Ring chromosome 9 with a 9p22.3-p24.3 duplication. Eur J Pediatr. 1999;158:791–3.CrossRef Seghezzi L, Maraschio P, Bozzola M, Maserati E, Tupler R, Marchi A, et al. Ring chromosome 9 with a 9p22.3-p24.3 duplication. Eur J Pediatr. 1999;158:791–3.CrossRef
5.
Zurück zum Zitat Knijnenburg J, van Haeringen A, Hansson KB, Lankester A, Smit MJ, Belfroid RD, et al. Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet. 2007;15:548–55.CrossRef Knijnenburg J, van Haeringen A, Hansson KB, Lankester A, Smit MJ, Belfroid RD, et al. Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet. 2007;15:548–55.CrossRef
6.
Zurück zum Zitat Rossi E, Riegel M, Messa J, Gimelli S, Maraschio P, Ciccone R, et al. Duplications in addition to terminal deletions are present in a proportion of ring chromosomes:clues to the mechanisms of formation. J Med Genet. 2008;45:147–54.CrossRef Rossi E, Riegel M, Messa J, Gimelli S, Maraschio P, Ciccone R, et al. Duplications in addition to terminal deletions are present in a proportion of ring chromosomes:clues to the mechanisms of formation. J Med Genet. 2008;45:147–54.CrossRef
7.
Zurück zum Zitat Kurtas N, Arrigoni F, Errichiello E, Zucca C, Maghini C, D'Angelo MG, et al. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2018;55(4):269–77.CrossRef Kurtas N, Arrigoni F, Errichiello E, Zucca C, Maghini C, D'Angelo MG, et al. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2018;55(4):269–77.CrossRef
8.
Zurück zum Zitat Lee S, Kyun Han D, Cho H, Cho YK, Ma JS. Mosaic ring chromosome 6 in an infant with significant patent Ductus Arteriosus and multiple congenital anomalies. J Korean Med Sci. 2012;27:948–52.CrossRef Lee S, Kyun Han D, Cho H, Cho YK, Ma JS. Mosaic ring chromosome 6 in an infant with significant patent Ductus Arteriosus and multiple congenital anomalies. J Korean Med Sci. 2012;27:948–52.CrossRef
9.
Zurück zum Zitat Mc Gowan-Jordan J, Simons A, Schmid M. An international system for human cytogenetic nomenclature. Basal: S. Kager; 2016. Mc Gowan-Jordan J, Simons A, Schmid M. An international system for human cytogenetic nomenclature. Basal: S. Kager; 2016.
12.
Zurück zum Zitat Guilherme RS, Meloni VFA, Kim CA, Pellegrino R, Takeno SS, Spinner NB, et al. Mechanisms of ring chromosome formation, ring instability and clinical consequences. BMC Med Genet. 2011;12:171.CrossRef Guilherme RS, Meloni VFA, Kim CA, Pellegrino R, Takeno SS, Spinner NB, et al. Mechanisms of ring chromosome formation, ring instability and clinical consequences. BMC Med Genet. 2011;12:171.CrossRef
15.
Zurück zum Zitat Ahzad HA, Ramli SF, Loong TM, Salahshourifar I, Zilfalil BA, Yusoff NM. De novo ring chromosome 6 in a child with multiple congenital anomalies. Kobe J Med Sci. 2010;56:E79–84.PubMed Ahzad HA, Ramli SF, Loong TM, Salahshourifar I, Zilfalil BA, Yusoff NM. De novo ring chromosome 6 in a child with multiple congenital anomalies. Kobe J Med Sci. 2010;56:E79–84.PubMed
16.
Zurück zum Zitat Walker ME, Salamon DAL, Milatovich A, Saal HM. Prenatal diagnosis of ring chromosome 6 in a fetus with hydrocephalus. PrenatDiagn. 1996;16:857–61. Walker ME, Salamon DAL, Milatovich A, Saal HM. Prenatal diagnosis of ring chromosome 6 in a fetus with hydrocephalus. PrenatDiagn. 1996;16:857–61.
17.
Zurück zum Zitat Kini KR, Van Dyke DL, Weiss L, Logan MS. Ring chromosome 6: case report and review of literature. Hum Genet. 1979;50:145–9.CrossRef Kini KR, Van Dyke DL, Weiss L, Logan MS. Ring chromosome 6: case report and review of literature. Hum Genet. 1979;50:145–9.CrossRef
18.
Zurück zum Zitat Fried K, Rosenblatt M, Mundel G, Krikler R. Mental retardation and congenital malformations associated with a ring chromosome 6. Clin Genet. 1975;7:192–6.CrossRef Fried K, Rosenblatt M, Mundel G, Krikler R. Mental retardation and congenital malformations associated with a ring chromosome 6. Clin Genet. 1975;7:192–6.CrossRef
19.
Zurück zum Zitat Zhang HZ, Li P, Wang D, Huffs NM, Qumsiyeh M, et al. FOXC1 gene deletion is associated with eye anomalies in ring chromosome 6. Am J Med Genet A. 2004;124A:280–7.CrossRef Zhang HZ, Li P, Wang D, Huffs NM, Qumsiyeh M, et al. FOXC1 gene deletion is associated with eye anomalies in ring chromosome 6. Am J Med Genet A. 2004;124A:280–7.CrossRef
21.
Zurück zum Zitat Andrieux J, Devisme L, Valat AS, Robert Y, Frnka C, Savary JB. Prenatal diagnosis of ring chromosome 6 in a fetus with cerebellar hypoplasia and partial agenesis of corpus callosum: case report and review of the literature. Eur J Med Genet. 2005;199:206. Andrieux J, Devisme L, Valat AS, Robert Y, Frnka C, Savary JB. Prenatal diagnosis of ring chromosome 6 in a fetus with cerebellar hypoplasia and partial agenesis of corpus callosum: case report and review of the literature. Eur J Med Genet. 2005;199:206.
24.
Zurück zum Zitat Hockner M, Utermann B, Erdel M. FauthC,Utermann G, Kotzot D. molecular characterization of a de novo ring chromosome 6 in a growth retarded but otherwise healthy woman. Am J Med Genet. 2008;146A:925–9.CrossRef Hockner M, Utermann B, Erdel M. FauthC,Utermann G, Kotzot D. molecular characterization of a de novo ring chromosome 6 in a growth retarded but otherwise healthy woman. Am J Med Genet. 2008;146A:925–9.CrossRef
25.
Zurück zum Zitat Nishi Y, Yoshimura O, Ohama K, Usui T. Ring chromosome 6: case report and review. Am J Med Genet. 1982;12:109–14.CrossRef Nishi Y, Yoshimura O, Ohama K, Usui T. Ring chromosome 6: case report and review. Am J Med Genet. 1982;12:109–14.CrossRef
26.
Zurück zum Zitat Linhares ND, Svartman M, Rodrigues TC, Rosenberg C, Valadares ER. Subtelomeric 6p25 deletion/duplication: report of a patient with new clinical findings and genotypephenotype correlations. Eur J Med Genet. 2015;58(5):310–8.CrossRef Linhares ND, Svartman M, Rodrigues TC, Rosenberg C, Valadares ER. Subtelomeric 6p25 deletion/duplication: report of a patient with new clinical findings and genotypephenotype correlations. Eur J Med Genet. 2015;58(5):310–8.CrossRef
27.
Zurück zum Zitat Miño CP, Benítez J, Ayuso C, Cascos SA. Ring chromosome 6: clinical and cytogenetic behaviour. Am J Med Genet. 1990;35(4):481–3.CrossRef Miño CP, Benítez J, Ayuso C, Cascos SA. Ring chromosome 6: clinical and cytogenetic behaviour. Am J Med Genet. 1990;35(4):481–3.CrossRef
28.
Zurück zum Zitat Carnevale A, Blanco B, Castillo J, Castillo V, Dominguez D. Ring chromosome 6 in a child with minimal abnormalities. Am J Med Genet. 1979;4:271–7.CrossRef Carnevale A, Blanco B, Castillo J, Castillo V, Dominguez D. Ring chromosome 6 in a child with minimal abnormalities. Am J Med Genet. 1979;4:271–7.CrossRef
30.
Zurück zum Zitat Nishimura DY, Searby CC, Alward WL, Walton D, Craig JE, Mackey DA, et al. A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet. 2001;68:364–72.CrossRef Nishimura DY, Searby CC, Alward WL, Walton D, Craig JE, Mackey DA, et al. A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet. 2001;68:364–72.CrossRef
31.
Zurück zum Zitat Lehmann OJ, Ebenezer ND, Ekong R, Ocaka L, Mungall AJ, Fraser S, et al. Ocular developmental abnormalities and glaucoma associated with interstitial 6p25 duplications and deletions. Invest Ophthalmol Vis Sci. 2002;43:1843–9.PubMed Lehmann OJ, Ebenezer ND, Ekong R, Ocaka L, Mungall AJ, Fraser S, et al. Ocular developmental abnormalities and glaucoma associated with interstitial 6p25 duplications and deletions. Invest Ophthalmol Vis Sci. 2002;43:1843–9.PubMed
32.
Zurück zum Zitat Seo S, Kume T. Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract. Dev Biol. 2006;296:421–36.CrossRef Seo S, Kume T. Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract. Dev Biol. 2006;296:421–36.CrossRef
34.
Zurück zum Zitat Roon WMC, Reid MSJ, Faull RLM, Snell RG. TATA-binding protein in neurodegenerative disease. Neuroscience. 2005;133:863–72.CrossRef Roon WMC, Reid MSJ, Faull RLM, Snell RG. TATA-binding protein in neurodegenerative disease. Neuroscience. 2005;133:863–72.CrossRef
35.
Zurück zum Zitat Rooms L, Reyniers E, Scheers S, Luijk RV, Wauters J, Aerschot LV, et al. TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions. Eur J Hum Genet. 2006;(10):1090–6. Rooms L, Reyniers E, Scheers S, Luijk RV, Wauters J, Aerschot LV, et al. TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions. Eur J Hum Genet. 2006;(10):1090–6.
Metadaten
Titel
A child with intellectual disability and dysmorphism due to complex ring chromosome 6: identification of molecular mechanism with review of literature
verfasst von
Frenny Sheth
Thomas Liehr
Viraj Shah
Hillary Shah
Stuti Tewari
Dhaval Solanki
Sunil Trivedi
Jayesh Sheth
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Italian Journal of Pediatrics / Ausgabe 1/2018
Elektronische ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-018-0571-0

Weitere Artikel der Ausgabe 1/2018

Italian Journal of Pediatrics 1/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.